Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations.

Saved in:
Bibliographic Details
Title: Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations.
Authors: Margetić, Sandra1 margeticsandra@gmail.com, Ćelap, Ivana1, Brkljačić, Diana Delić2, Pavlović, Nikola2, Goreta, Sandra Šupraha3, Kobasić, Ivana4, Lovrenčić-Huzjan, Arijana4, Kes, Vanja Bašić4
Source: Biochemia Medica. Feb2020, Vol. 30 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Description
ISSN:13300962
DOI:10.11613/BM.2020.010702